Cite
Cardiovascular magnetic resonance T2* mapping for the assessment of cardiovascular events in hypertrophic cardiomyopathy
MLA
Frank Ruschitzka, et al. Cardiovascular Magnetic Resonance T2* Mapping for the Assessment of Cardiovascular Events in Hypertrophic Cardiomyopathy. Jan. 2020. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....280089966b1141af653b453799202c96&authtype=sso&custid=ns315887.
APA
Frank Ruschitzka, Christiane Gruner, Karin Labucay, Robert Manka, Jochen von Spiczak, Alexander Gotschy, Malte Kelm, Florian Boenner, Malgorzata Polacin, Hatem Alkadhi, Mareike Gastl, & Sebastian Kozerke. (2020). Cardiovascular magnetic resonance T2* mapping for the assessment of cardiovascular events in hypertrophic cardiomyopathy.
Chicago
Frank Ruschitzka, Christiane Gruner, Karin Labucay, Robert Manka, Jochen von Spiczak, Alexander Gotschy, Malte Kelm, et al. 2020. “Cardiovascular Magnetic Resonance T2* Mapping for the Assessment of Cardiovascular Events in Hypertrophic Cardiomyopathy,” January. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....280089966b1141af653b453799202c96&authtype=sso&custid=ns315887.